Small Molecule Drugs Targeting Non-Coding RNAs as Treatments for Alzheimer’s Disease and Related Dementias
Open Access
Abstract
Despite the enormous burden of Alzheimer’s disease and related dementias (ADRD) on patients, caregivers, and society, only a few treatments with limited efficacy are currently available. While drug development conventionally focuses on disease-associated proteins, RNA has recently been shown to be druggable for therapeutic purposes as well. Approximately 70% of the human genome is transcribed into non-protein-coding RNAs (ncRNAs) such as microRNAs, long ncRNAs, and circular RNAs, which can adopt diverse structures and cellular functions. Many ncRNAs are specifically enriched in the central nervous system, and their dysregulation is implicated in ADRD pathogenesis, making them attractive therapeutic targets. In this review, we first detail why targeting ncRNAs with small molecules is a promising therapeutic strategy for ADRD. We then outline the process from discovery to validation of small molecules targeting ncRNAs in preclinical studies, with special emphasis on primary high-throughput screens for identifying lead compounds. Screening strategies for specific ncRNAs will also be included as examples. Key challenges—including selecting appropriate ncRNA targets, lack of specificity of small molecules, and general low success rate of neurological drugs and how they may be overcome—will be discussed throughout the review.Keywords
Funding Information
- National Institute of Health (AG060019, AG069127)
This publication has 140 references indexed in Scilit:
- Alteration of the microRNA network during the progression of Alzheimer's diseaseEMBO Molecular Medicine, 2013
- The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expressionGenome Research, 2012
- Cell-Type-Based Analysis of MicroRNA Profiles in the Mouse BrainNeuron, 2012
- Identification of Small Molecules That Suppress MicroRNA Function and Reverse TumorigenesisJournal of Biological Chemistry, 2010
- MicroRNA-101 Regulates Amyloid Precursor Protein Expression in Hippocampal NeuronsJournal of Biological Chemistry, 2010
- Evidence for natural antisense transcript-mediated inhibition of microRNA functionGenome Biology, 2010
- Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretaseNature Medicine, 2008
- Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expressionProceedings of the National Academy of Sciences, 2008
- Specific expression of long noncoding RNAs in the mouse brainProceedings of the National Academy of Sciences, 2008
- Dendritic BC200 RNA in aging and in Alzheimer's diseaseProceedings of the National Academy of Sciences, 2007